Morishita Kiyofumi, Kawaharada Nobuyoshi, Fukada Johji, Hachiro Yoshikazu, Kurimoto Yoshihiko, Fujisawa Yasuaki, Saito Tatsuya, Abe Tomio
Department of Thoracic and Cardiovascular Surgery, Sapporo Medical University School of Medicine, South 1 West 16, Central Ward, Sapporo 060-8543, Japan.
Artif Organs. 2005 Apr;29(4):300-5. doi: 10.1111/j.1525-1594.2005.29051.x.
We have performed descending thoracic aortic aneurysm repairs with partial cardiopulmonary bypass, including heparin-coated circuits. The aim of this study was to evaluate (i) the impact of partial cardiopulmonary bypass on distal organ function and surgical outcomes; and (ii) the effectiveness of using heparin-coated circuits for preventing bleeding complications.
From July 1980 to June 2004, 309 patients underwent descending thoracic aortic aneurysm repairs using partial cardiopulmonary bypass. Their mean age was 61 years (range 19-81 years). One hundred of the 309 patients underwent repair of descending thoracic aortic aneurysm with heparin-coated circuits. Blood data for renal and hepatic function were collected on the day before the operation and postoperative days.
The in-hospital mortality was 15%. Distal organ dysfunction included spinal cord dysfunction in 2 patients (0.7%) and renal failure necessitating hemodialysis in 15 patients (5%, 15/297: excluded 12 dialysis patients). Multivariate analyses showed that preoperative hemodialysis and emergency operation were risk factors for operative mortality and that emergency operation was a risk factor for requiring hemodialysis. Renal and hepatic function normalized by 2 weeks after surgery. There were no significant differences between the heparin-coated group and nonheparin-coated group in amounts of packed red cells, fresh frozen plasma, and platelets transfused during the procedures.
Our data showed that partial cardiopulmonary bypass is a safe and effective method for distal perfusion. Using this technique, descending thoracic aortic aneurysm repair can be performed with acceptable mortality and morbidity. However, the superiority of heparin-coated circuits over nonheparin-coated ones was not proved.
我们已采用部分体外循环(包括肝素涂层回路)进行降主动脉瘤修复术。本研究的目的是评估:(i)部分体外循环对远端器官功能和手术结果的影响;(ii)使用肝素涂层回路预防出血并发症的有效性。
从1980年7月至2004年6月,309例患者采用部分体外循环进行降主动脉瘤修复术。他们的平均年龄为61岁(范围19 - 81岁)。309例患者中有100例使用肝素涂层回路进行降主动脉瘤修复。在手术前一天及术后收集肾功能和肝功能的血液数据。
住院死亡率为15%。远端器官功能障碍包括2例脊髓功能障碍(0.7%)和15例需要血液透析的肾衰竭患者(5%,15/297:排除12例透析患者)。多因素分析显示,术前血液透析和急诊手术是手术死亡率的危险因素,急诊手术是需要血液透析的危险因素。术后2周肾功能和肝功能恢复正常。在手术过程中,肝素涂层组和非肝素涂层组在输注的红细胞压积、新鲜冰冻血浆和血小板数量方面无显著差异。
我们的数据表明,部分体外循环是一种安全有效的远端灌注方法。使用该技术,降主动脉瘤修复术可以在可接受的死亡率和发病率下进行。然而,肝素涂层回路相对于非肝素涂层回路的优越性未得到证实。